Bích-Mây Nguyễn :verified: on Nostr: "Cigna said on Monday it will remove AbbVie’s blockbuster rheumatoid arthritis drug ...

"Cigna said on Monday it will remove AbbVie’s blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement in 2025, and recommend less pricey biosimilar versions of the medicine instead...Humira was once the world's biggest selling prescription medicine with peak sales of $21.2 billion in 2022."

https://www.reuters.com/business/healthcare-pharmaceuticals/cigna-remove-abbvies-humira-some-drug-reimbursement-lists-next-year-2024-08-26/

#healthcare #drugs #DrugPrices #PhRMA #CostsOfCare #PBMs #insurance #HealthPolicy